Abstract
Roche et al (Pediatrics 63:847, 1979) have provided a good clinical review of recent data on stimulant-induced growth disturbances in hyperkinetic children. They have clearly shown that substantial differences exist among published studies in methodology used, drug dosages employed, and measurement techniques cited. The clinician in the field needs this type of review to clarify the confusing reports on stimulant side effects. We wish to make two points. The authors might have stressed that the stimulant drugs available may have differential growth suppression effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
